Global cerebral atrophy in early stages of Huntington's disease: Quantitative MRI study

NeuroReport

Volumn 15, Issue 2, 2004, Pages 363-365

  Kassubek, Jan ^a   Landwehrmeyer, G Bernhard ^a   Ecker, Daniel ^a   Juengling, Freimut D ^b   Muche, Rainer ^a   Schuller, Sabine ^c   Weindl, Adolf ^c   Peinemann, Alexander ^c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aging; Atrophy; Brain parenchymal fraction; Huntington's disease; Magnetic resonance imaging; Neurodegenerative disease

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ATROPHY; CEREBRAL CORTEX; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 1542320248     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200402090-00030     Document Type: Article

References (14)

1. Vonsattel JPG and DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 57, 369-384 (1998).
2. Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 60, 1615-1620 (2003).
3. Ho VB, Chuang HS, Rovira MJ and Koo B. Juvenile Huntington disease: CT and MR features. Am J Neuroradiol 16, 1405-1412 (1995).
4. Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ and Miller DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125, 327-337 (2002).
5. Kassubek J, Tumani H, Ecker D, Kurt A, Ludolph AC and Juengling FD. Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study. Neuroreport 14, 427-443 (2003).
6. Juengling FD and Kassubek J. Standardized calculation of brain parenchymal fraction: an approach to objective assessment of cerebral atrophy. Am J Neuroradiol 24, 1492-1493 (2003).
7. Shoulson I and Fahn S. Huntington's disease: clinical care and evaluation. Neurology 29, 1-3 (1979).
8. Friston KJ, Ashburner J, Poline JB, Frith CD, Heather JD and Frackowiak RSJ. Spatial registration and normalisation of images. Hum Brain Mapp 2, 165-189 (1995).
9. Chard DT, Parker GJ, Griffin CM, Thompson AJ and Miller DH. The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 15, 259-267 (2002).
10. Pedhazur EJ. Multiple Regression in Behavioral Research: Explanation and Prediction. New York: Holt, Rinehart and Winston; 1982.
11. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL and Toga AW. Mapping cortical change across the human life span. Nature Neurosci 6, 309-315 (2003).
12. Kassubek J, Juengling FD, Hoffmann S, Rosenbohm A, Kurt A, Jurkat-Rott K et al. Quantification of brain atrophy in myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study. Neurosci Lett 348, 73-76 (2003).
13. Lüders E, Steinmetz H and Jäncke L. Brain size and grey matter volume in the healthy human brain. Neuroreport 13, 2371-2374 (2002).
14. Kassubek J, Juengling FD, Kioschies T, Henkel K, Karitzky J, Kramer B et al. Topography of cerebral atrophy in early Huntington's disease: a voxel-based morphometric MRI study. J Neurol Neurosurg Psychiatry, in press.